Many physiological processes exhibit diurnal variations that persist even in the absence of environmental timing cues. These rhythmic changes in physiology that operate to anticipate the needs of the organism and show a periodicity of about 24 hours are called circadian rhythms. Circadian rhythms are present in central and peripheral tissues and generated by an intracellular oscillating timing mechanism known as the circadian oscillator or molecular clock ([@bibr11-0748730411401579]; [@bibr27-0748730411401579]; [@bibr53-0748730411401579]).

The mammalian molecular clock relies on a transcriptional-translational feedback loop in which BMAL1 and CLOCK bind as heterodimers to regulatory elements on target genes, stimulating their transcription ([@bibr9-0748730411401579]; [@bibr43-0748730411401579]). Among those genes are the repressor proteins *PERIOD* (*PER*) and *CRYPTOCHROME* (*CRY*) families. Once PER and CRY have reached a critical concentration and are appropriately modified, they inhibit the activity of BMAL1-CLOCK, thereby repressing their own transcription and that of the other BMAL1-CLOCK target genes. Following additional modifications, PER and CRY are degraded, and the cycle begins again ([@bibr8-0748730411401579]; [@bibr10-0748730411401579]; [@bibr12-0748730411401579]; [@bibr17-0748730411401579]; [@bibr31-0748730411401579]). A second interconnecting feedback loop involving orphan nuclear receptors of the Rev-erb and ROR families regulates the levels of expression of *BMAL1, CLOCK*, and *CRY1*. In this secondary loop, ROR members activate both *BMAL1* and Rev-erbα expression, while in turn, Rev-erbα represses transcription of both itself and *BMAL1*, closing the loop ([@bibr1-0748730411401579]; [@bibr11-0748730411401579]; [@bibr33-0748730411401579]; [@bibr44-0748730411401579]). These nuclear receptors are not essential for circadian rhythms but are thought to improve the robustness of the clock, affecting its period length and phase-shifting properties ([@bibr1-0748730411401579]; [@bibr33-0748730411401579]). In addition, these nuclear receptors are thought to be links between circadian rhythms and metabolism ([@bibr11-0748730411401579]; [@bibr45-0748730411401579]).

Several lines of evidence show a strong interplay between metabolism and circadian rhythms ([@bibr11-0748730411401579]; [@bibr13-0748730411401579]; [@bibr14-0748730411401579]). Transcriptome profiling studies revealed that several key genes involved in metabolism are rhythmically expressed ([@bibr41-0748730411401579]; [@bibr52-0748730411401579]). Mice devoid of a functional circadian oscillator develop metabolic syndrome, and mutations or ablations of clock genes are often associated with metabolic problems ([@bibr13-0748730411401579]; [@bibr16-0748730411401579]; [@bibr49-0748730411401579]). Conversely, the dominance of feeding cycles as a zeitgeber (time cue) for peripheral clocks implies that metabolic signals impact the clock machinery itself ([@bibr2-0748730411401579]; [@bibr7-0748730411401579]; [@bibr13-0748730411401579]).

Glucose and lipid metabolism in the liver and adipose tissue exhibit circadian variations due, at least in part, to circadian expression of key enzymes in these pathways ([@bibr29-0748730411401579]; [@bibr41-0748730411401579]; [@bibr47-0748730411401579]; [@bibr57-0748730411401579]). The expression of these genes is regulated by several pathways including nuclear receptor signaling ([@bibr6-0748730411401579]; [@bibr28-0748730411401579]; [@bibr30-0748730411401579]; [@bibr48-0748730411401579]), and interestingly, a number of nuclear receptors are themselves expressed in a circadian manner. Thus, in addition to *Rev-erb*α, the expression of peroxisome proliferator--activated receptors (PPARs), estrogen-related receptors (ERRs), and thyroid hormone receptors (TRs) is subject to circadian control in liver, muscle, and adipose tissues ([@bibr52-0748730411401579]). Furthermore, the ability of nuclear receptors to stimulate the expression of metabolic genes depends on the recruitment of coactivators whose activity and/or expression not only varies in response to environmental stimuli but that are also expressed in a circadian manner ([@bibr3-0748730411401579]; [@bibr34-0748730411401579]; [@bibr38-0748730411401579]; [@bibr41-0748730411401579]). For example, PGC1α and PGC1β, which are coactivators for ERRs and PPARs, are responsible for the activation of catabolic gene expression in metabolic tissues ([@bibr19-0748730411401579]). The expression of these 2 cofactors is increased following exercise and stress or in cold temperatures, but it is also subject to circadian control ([@bibr19-0748730411401579]; [@bibr34-0748730411401579]).

RIP140 is a corepressor for many catabolic genes and antagonizes the positive effects of PGC1 coactivators ([@bibr6-0748730411401579]; [@bibr18-0748730411401579]; [@bibr51-0748730411401579]). Thus, catabolism is increased in mice devoid of RIP140, and they are lean and protected against diet-induced obesity and insulin resistance ([@bibr32-0748730411401579]). On the other hand, RIP140 functions as a coactivator for a number of genes involved in triglyceride synthesis ([@bibr21-0748730411401579]), growth factors of the EGF family ([@bibr39-0748730411401579]), and inflammatory cytokines ([@bibr56-0748730411401579]). Transcriptome profiling has shown that RIP140 mRNA is subject to circadian oscillations in the liver ([@bibr23-0748730411401579]; [@bibr41-0748730411401579]), and we have previously noted alterations in the daily patterns of rest/activity in RIP140-null mice kept in normal 12-hour light/12-hour dark conditions ([@bibr22-0748730411401579]). In view of these observations, we have examined the relationship between this metabolic cofactor and the molecular clock. We have found that RIP140 is not only subject to circadian gene expression but also functions as a positive regulator of the molecular clock by potentiating the activity of retinoid-related orphan receptor α (RORA).

Materials and Methods {#section1-0748730411401579}
=====================

Animal Samples {#section2-0748730411401579}
--------------

Three-month-old wild-type and RIP140 knockout male mice of the C57BL/6J background were kept in a 12-hour light/12-hour dark cycle with regular chow provided ad libitum. Animals were sacrificed in groups of 3 of each genotype per day on 2 consecutive days (to avoid excessive time difference between sample 1 and 6 of the same genotype), and tissue samples were preserved in RNALate (Invitrogen, Carlsbad, CA) for RNA extraction.

Quantitative Real-Time RT-PCR {#section3-0748730411401579}
-----------------------------

Total RNA was purified from tissues and cells using TriReagent (Sigma-Aldrich, St. Louis, MO). For reverse transcription (RT), RNA (1 µg) was reverse transcribed to cDNA using SuperScript II Reverse Transcriptase (Invitrogen) and random hexamers (Invitrogen). Quantitative PCR (QPCR) was performed on diluted cDNA samples with SYBR Green JumpStart Taq ReadyMix (Sigma-Aldrich) in an ABI Step One Plus QPCR system (Applied Biosystems, Carlsbad, CA) using the following program: 95 °C for 10 minutes, 40 cycles at 95 °C for 15 seconds, 60 °C for 30 seconds, and 72 °C for 30 seconds. Primers used are listed in Supplementary Table S1 and were designed using Primer3 (<http://frodo.wi.mit.edu/primer3>). RT-QPCR results were analyzed using the 2^−ΔΔCt^ method as described by [@bibr36-0748730411401579]. The geometric mean of 3 housekeeping genes---β-2 microglobulin (B2m), ribosomal protein L13A (RPL13a), and TATA box binding protein (Tbp, for mice) or ribosomal protein L19 (RPL19, for humans)---was used as a calibrator after confirming that the genes were not affected by the treatment ([@bibr36-0748730411401579]).

Cell Culture {#section4-0748730411401579}
------------

All cells were cultured under humidified 10% CO~2~ at 37 °C in high glucose Dulbecco's modified Eagle's medium (cat. no. 41966, Invitrogen) supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 100 µg/mL streptomycin, 0.25 µg/mL amphotericin, and Glutamax (Invitrogen).

Synchronization by Serum Pulse {#section5-0748730411401579}
------------------------------

Cells were cultured at confluence for 2 days in 10% FBS-DMEM. Synchronization was achieved by incubation in DMEM supplemented with 50% horse serum (PAA) for 2 hours. After this incubation, cells were washed with PBS and placed in serum-free medium (time zero). Protein and mRNA samples were collected every 3 hours for 51 hours.

Mouse embryonic fibroblasts (MEFs) were isolated from 12.5-day-old embryos produced by crossing heterozygous RIP140 knockout mice. In brief, embryos were carefully detached from the amniotic sac, and each embryo was placed in individual 3.5-cm dishes and decapitated. Bodies were finely minced with scissors in 1X Trypsin/EDTA (Invitrogen), and the fragments were pipetted up and down using a 5-mL plastic Pasteur pipette. Trypsin was then blocked by adding 10% FBS-DMEM. Cellular debris was allowed to settle for 2 minutes, and the medium containing the cell suspension was transferred to a 25-cm flask. Embryos were genotyped during expansion (passage 2) and used for experiments between passages 3 and 12. Each MEF line corresponds to an individual embryo.

Immunoblotting and Antibodies {#section6-0748730411401579}
-----------------------------

Cell lysates were harvested by the addition of SDS lysis buffer (2% SDS, 30 mM NaCl, 10 mM HEPES, pH 7.4, 20 mM NaF, 1 mM NaPPi, 1 mM PMSF, and 1X Complete Protease Inhibitor Cocktail \[Roche, Basel, Switzerland\]). Equal amounts of protein from lysates were resolved by SDS-PAGE, immunoblotted, and detected with an ECL or ECLplus kit (GE Healthcare, Little Chalfont, UK). For antibodies, anti-RIP140 monoclonal antibody (6D7) generated against residues 301 to 478 of human RIP140 was described previously ([@bibr21-0748730411401579]). The following antibodies were used: anti-RORA (sc-6062, Santa Cruz Biotechnology, Santa Cruz, CA), anti--β-actin (ab8226, Abcam, Cambridge, UK), anti-HA (11867423, Roche), anti-V5 (R960-25, Invitrogen), and normal mouse or goat immunoglobulin G (IgG) (sc-2025 or sc-2028, Santa Cruz Biotechnology).

Transient Transfection {#section7-0748730411401579}
----------------------

pCIEF-V5RIP140 expression vector was described previously ([@bibr39-0748730411401579]). The *BMAL1* and 2XmtROREs-*BMAL1* promoter reporters and pcDNA3-RORA1 and pcDNA3-Rev-erbα expression constructs were described ([@bibr1-0748730411401579]) and kindly provided by Professor T. T. Takumi. pSPORT6-RORC was purchased from I.M.A.G.E. Consortium (Manassas, VA). RNA duplexes to knock down RIP140, RORA, Rev-erbα, and noncoding control siRNA duplexes were purchased from NBS Biologicals (Huntingdon, UK), and sequences are shown in Supplementary Table S2.

Cells were plated in 24-well plates, 5 × 10^4^ cells per well, in phenol red--free Optimem (Invitrogen) supplemented with 2% FBS 1 day prior to transfection. Cells were transfected using FuGene HD (Roche) or Lipofectamine 2000 (in RNAi experiments) (Invitrogen) according to the instructions of the manufacturer. In all cases, less than 100 ng of DNA was used. Empty pCIEF and/or pcDNA3 vectors were used to adjust the same amount of DNA in all treatments. There were 50 ng of *BMAL1* or 2XmtROREs-*BMAL1* promoter reporter and 5 ng of pcDNA4-eGFP used in all the experiments. The amount of RORA and RORC expression vectors varied between 0.1 and 1 ng, Rev-erbα expression vector between 10 and 30 ng, and the amount of RIP140 expression vector between 3 and 27 ng. Cells were harvested for luciferase assay approximately 36 hours after transfection. Firefly luciferase was measured with Steadylite HTS (PerkinElmer, Waltham, MA) according to the instructions of the manufacturer. In all cases, cells were cotransfected with pcDNA4-eGFP, and 480/535 fluorescence was used as an internal control to correct for differences in transfection efficiencies.

Real-Time Luciferase Assay {#section8-0748730411401579}
--------------------------

RIP140--/-- cells were cotransfected with *pBMAL1*-dLUC ([@bibr15-0748730411401579]) and pBABE- puro (Addgene, Cambridge, MA) using FuGene 6 (Roche) following the manufacturer's instructions. Clones of stably transfected cells were then generated by adding puromycin (1.5 µg/mL) for approximately 1 month, and individual colonies were selected and assayed for luciferase activity in a Turner TD-20e luminometer using 1 mM luciferin in PBS (Gold Biotechnology, St. Louis, MO). Luciferase-positive clones were then assayed for clock function in a LumiCycle (Actimetrics, Wilmette, IL) as previously described ([@bibr15-0748730411401579]). The period length (τ) was calculated using the sine fit (damped) function from the LumiCycle analysis software package (Actimetrics), and the phase (φ) was calculated using the second peak after release from serum shock as a reference.

Immunoprecipitation {#section9-0748730411401579}
-------------------

Proteins were crosslinked using 2 mM DSP (Pierce, Waltham, MA) according to the manufacturer's instructions for 30 minutes. Cells were lysed in SDS lysis buffer (2% SDS, 30 mM NaCl, 10 mM HEPES, pH 7.4, 20 mM NaF, 1 mM NaPPi, 1 mM PMSF, and 1X Complete Protease Inhibitor Cocktail \[Roche\]). Immunoprecipitation was carried out using Dynabeads Protein A Immunoprecipitation Kit (Invitrogen) following the manufacturer's instructions. After immunoprecipitation, samples were decrosslinked by heating at 95 °C in 10% β-mercaptoethanol for 5 minutes.

Chromatin Immunoprecipitation (ChIP) Assay {#section10-0748730411401579}
------------------------------------------

Cells were crosslinked (1% formaldehyde for 15 minutes) and nuclei isolated by scraping the cells in swelling buffer (25 mM HEPES, pH 7.9, 1.5 mM MgCl~2~, 10 mM KCl, and 0.1% Nonidet, supplemented with protease inhibitor cocktail \[Roche\] and 1 mM PMSF) followed by centrifugation for 5 minutes at 14,000*g*. Nuclei were sonicated in lysis buffer (1% SDS, 1% Triton-X100, 0.5% deoxycholate, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1) for 30 minutes. Chromatin (500 µg) was immunoprecipitated using Dynabeads Protein A Immunoprecipitation Kit (Invitrogen) following the manufacturer's instructions with minor changes. Washes were performed as follows: 1X low salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM TRIS-HCl, pH 8.1, 150 mM NaCl); 2X high salt (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM TRIS-HCl, pH 8.1, 500 mM NaCl); 1X LiCl buffer (0.25 M LiCl, 1% NP-40, 1% deoxycholate, 1 mM EDTA, 10 mM TRIS-HCl, pH 8.1); and 2X TE buffer (10 mM TRIS-HCl, pH 8, 1 mM EDTA). Samples were eluted in 100 L of EB buffer (1% SDS and 1 mL 0.1 M NaHCO~3~). For rechip experiments, samples were eluted in 50 mL of 10 mM DTT at 37 °C for 30 minutes and then diluted in 2 mL of low salt buffer and immunoprecipitated as indicated above. After reversal of crosslinking, DNA fragments were purified from the samples with a QIAquick PCR purification kit (Qiagen, Venlo, the Netherlands) and used as templates in QPCRs. Primers used are listed in Supplementary Table S3 and were designed using Primer3 (<http://frodo.wi.mit.edu/primer3>).

Statistical Analysis {#section11-0748730411401579}
--------------------

Results were analyzed with Prism 4 (GraphPad Software, La Jolla, CA) using the Student *t* test or ANOVA followed by the Student Newman-Keuls multiple comparison test according to experimental design. *p* values lower than 0.05 were considered evidence for statistical significance.

Results {#section12-0748730411401579}
=======

RIP140 Protein and mRNA Levels Exhibit Circadian Oscillations {#section13-0748730411401579}
-------------------------------------------------------------

Inspection of a circadian gene expression database from mouse liver indicated that RIP140 was subject to circadian oscillation ([@bibr23-0748730411401579]; [@bibr41-0748730411401579]). To investigate whether this periodicity was cell autonomous, we analyzed RIP140 expression in synchronized HepG2 human liver cells. Cells were synchronized by a serum pulse, and samples of mRNA and protein were collected every 3 hours for 51 hours. We found that RIP140 mRNA and protein were expressed in a circadian fashion, indicating that this is an intrinsic property of liver cells ([Fig. 1A](#fig1-0748730411401579){ref-type="fig"} and [1B](#fig1-0748730411401579){ref-type="fig"}). It is interesting to note that there was a phase difference between RIP140 mRNA and protein that is typical for many clock genes ([@bibr12-0748730411401579]; [@bibr35-0748730411401579]). Initially, we investigated whether BMAL1 directly controls RIP140 expression by depleting it from U2OS cells using RNA interference (RNAi). As expected, the depletion of BMAL1 led to a decrease in mRNA of its well-known target *Rev-erb*α, but interestingly, it resulted in an increase in RIP140 expression, indicating that RIP140 expression is not activated by BMAL1 but may be subject to repression by Rev-erbα ([Fig. 1C](#fig1-0748730411401579){ref-type="fig"}). While canonical E-boxes were not evident within the *RIP140* locus, ROR binding elements (RORE) were noted in intronic regions of the gene ([@bibr20-0748730411401579]). Consistent with these observations, the depletion of Rev-erbα by RNAi increased the levels of RIP140 mRNA ([Fig. 1C](#fig1-0748730411401579){ref-type="fig"}). Thus, Rev-erbα seems to repress the expression of RIP140 and may mediate the effects of BMAL1 on RIP140 expression, but whether this repressive effect is direct cannot be ascertained from these results alone.

![Circadian expression of RIP140. (A) Western blots for RIP140 and β-actin, representative of 2 independent experiments. (B) Levels of RIP140 mRNA, measured by real-time PCR, and protein (measured by densitometry of A). Points represent mean ± SEM (*n* = 4). Figure representative of 3 independent experiments. Cells were synchronized by 50% serum pulse as described in Materials and Methods. (C) mRNA levels for BMAL1, RIP140, and Rev-erbα after depletion of BMAL1 using a specific siRNA for BMAL1 and levels of Rev-erbα and RIP140 mRNA after depletion of Rev-erbα using a specific siRNA for Rev-erbα. U2OS cells were transfected with siRNA, and mRNA was collected 48 hours after transfection. Bars represent mean ± SEM. \**p* \< 0.05, \*\**p* \< 0.01, and \*\*\**p* \< 0.001 versus control. Student *t* test (*n* = 6). Figure representative of 3 independent experiments. (D) Levels of *BMAL1, fatty acid synthase (FAS), sterol regulatory element-binding protein 1c (SREBP1c)*, and *phospho enol pyruvate carboxykinase (PEPCK)* mRNA, superimposed on RIP140 protein levels. Points represent mean ± SEM of 4 biological replicates.](10.1177_0748730411401579-fig1){#fig1-0748730411401579}

A number of metabolic genes, such as FAS, SREBP1c, PEPCK, G6Pase, PDK4, and others, that display circadian oscillations in the liver are known targets for RIP140 ([@bibr6-0748730411401579]; [@bibr21-0748730411401579]; [@bibr41-0748730411401579]; [@bibr51-0748730411401579]). The pattern of expression of these genes overlapped with the changes in RIP140 protein, indicating that RIP140 and its associated metabolic pathways are controlled in a coordinated fashion. There was also a particularly marked overlap between RIP140 protein and *BMAL1* expression ([Fig. 1D](#fig1-0748730411401579){ref-type="fig"}).

RIP140 Regulates the Basal Expression of Clock Genes In Vivo and In Vitro {#section14-0748730411401579}
-------------------------------------------------------------------------

Given the oscillations in RIP140 expression, we examined the possibility that it might participate in a feedback mechanism to signal back to the molecular clock. We investigated the impact of RIP140 on the expression of *BMAL1* and other clock genes, determining their mRNA levels in the liver and anterior hypothalamus (AHT) of wild-type (WT) and RIP140 knockout (KO) mice. Samples were collected at ZT2, and mRNA levels for different clock genes were measured by RT-QPCR. At this time point, there was a consistent reduction in the RNA levels for all clock genes studied in the AHT and of *BMAL1, CLOCK*, and *CRY1* in the liver of KO animals ([Fig. 2A](#fig2-0748730411401579){ref-type="fig"}). The only exception was *PER2*, which was increased in the liver ([Fig. 2A](#fig2-0748730411401579){ref-type="fig"}). Similarly, the depletion of RIP140 from HepG2 cells by constitutively expressing RIP140 shRNA also led to a reduction in clock gene expression as compared with a scrambled shRNA control cell line ([Fig. 2B](#fig2-0748730411401579){ref-type="fig"}). Conversely, exogenous expression of RIP140 led to an increase in the levels of *BMAL1* and *CLOCK* ([Fig. 2C](#fig2-0748730411401579){ref-type="fig"}). Thus, we conclude that RIP140 functions as a positive regulator of clock gene expression.

![RIP140 absence reduces the basal expression of clock genes. (A) mRNA level of different clock genes in the liver and anterior hypothalamus (AHT) of wild-type (WT) and RIP140 knockout (KO) mice. Samples were collected at ZT2 (2 hours after lights are turned on), and mRNA was extracted and quantified by RT-QPCR. Bars represent mean ± SEM. \**p* \< 0.05, \*\**p* \< 0.01, and \*\*\**p* \< 0.001 versus control. Student *t* test (*n* = 6). (B) mRNA levels of clock genes in HepG2 human liver cell lines depleted of RIP140 quantified by RT-QPCR. RIP140 knockdown cells (shRIP) were generated by stably transfecting HepG2 cells with a vector expressing RIP140-specific shRNA. HepG2 cells constitutively expressing a nonspecific scrambled shRNA (scr) were used as a control. (Inset) Western blot showing RIP140 expression in the different cell lines. Bars represent mean ± SEM (*n* = 6). \**p* \< 0.05, \*\**p* \< 0.01, and \*\*\**p* \< 0.001 versus control. Student *t* test. (C) mRNA levels of clock genes in HuH7 human liver cells transiently transfected with a RIP140 expressing vector or equal amounts of an eGFP expressing vector. Bars represent mean ± SEM (*n* = 3). \**p* \< 0.05 and \*\**p* \< 0.01 versus control. Student *t* test.](10.1177_0748730411401579-fig2){#fig2-0748730411401579}

The Absence of RIP140 Influences the Level of Expression of Clock Genes in Synchronized MEFs {#section15-0748730411401579}
--------------------------------------------------------------------------------------------

To investigate the role of RIP140 in circadian gene expression, we compared the expression of clock genes in mouse embryonic fibroblasts (MEFs) from WT and KO littermates. As in the mouse liver, AHT, and RIP140-depleted HepG2s, unsynchronized MEFs devoid of RIP140 express less mRNA for several clock genes including *BMAL1, CLOCK*, and *CRY1* ([Fig. 3A](#fig3-0748730411401579){ref-type="fig"}). After serum pulse synchronization, the circadian expression of *BMAL1, CRY1*, and *PER1* was maintained in the absence of RIP140, but the amplitude of the oscillations was reduced for *BMAL1* and *CRY1*. Interestingly, a slight phase difference in *BMAL1* and *CRY1* expression between WT and KO MEFs was also observed in the RT-QPCR data ([Fig. 3B](#fig3-0748730411401579){ref-type="fig"}). However, this observation was not consistent with the phase of expression seen for *PER1*. Because phase and period estimates based on sampling of RNAs followed by RT-QPCR are limited by both the density of time points and the duration of experiments, we generated stably transfected lines of RIP140 KO MEFs in which the *BMAL1* promoter (pBMAL1-dLuc) was used to drive rhythmic expression of firefly luciferase. In 7 independently derived clones, experiments monitored during 6 days provided consistent phase and period determinations of *BMAL1* reporter activity in the RIP140 KO MEFs ([Fig. 3C](#fig3-0748730411401579){ref-type="fig"}). The phase of peak *BMAL1* promoter activity on day 2 was 34.32 ± 0.62 hours (2 standard deviations) after serum shock and is in agreement with prior estimates of phase from the NIH 3T3 cell line (33.99 ± 0.22) ([@bibr15-0748730411401579]). This phase falls within the region spanning the peaks for *BMAL1* mRNA in RIP140 KO and WT littermate MEFs ([Fig. 3B](#fig3-0748730411401579){ref-type="fig"}), suggesting that the apparent phase differences mainly reflect biological variability. Thus, while RIP140 is not required to maintain circadian rhythmicity, it contributes to the overall expression and oscillation of *BMAL1* and *CRY1*.

![Clock gene expression and circadian rhythms in RIP140 knockout (KO) mouse embryonic fibroblasts (MEFs). The MEFs were generated as described in Materials and Methods by crossing RIP140 KO heterozygous animals. (A) Level of expression of clock genes in unsynchronized MEFs generated from 2 wild-type (WT1/2) and 2 knockout (KO1/2) embryos measured by real-time PCR. Bars represent mean ± SEM (*n* = 6). \**p* \< 0.05, \*\**p* \< 0.01, and \*\*\**p* \< 0.001 versus WT1. One-way ANOVA followed by Student Newman-Keuls post hoc multiple comparison test. Figure representative of 3 independent experiments. (B) Daily oscillations in the mRNA levels of *BMAL1, CRY1*, and *PER1* in synchronized WT and KO MEFs measured by real-time PCR. Cells were synchronized by 50% serum pulse as described in Materials and Methods. (C) RIP140 KO MEFs were stably transfected with the BMAL1 promoter driving luciferase. Seven individual clones (clone 1-7) were assayed for rhythmicity. After synchronization by serum pulse, luciferase activity was measured in a real-time luminometer for 6 days. τ and φ were calculated as described in Materials and Methods (*N* = 7).](10.1177_0748730411401579-fig3){#fig3-0748730411401579}

RIP140 Affects *BMAL1* Expression by Coactivation of RORA {#section16-0748730411401579}
---------------------------------------------------------

RIP140 has been reported to interact with most, if not all, nuclear receptors ([@bibr51-0748730411401579]) and a number of other transcription factors, including p65, CREB, and c-jun ([@bibr39-0748730411401579]; [@bibr56-0748730411401579]). Retinoid-related orphan receptor α (RORA) is a nuclear receptor well known to stimulate transcription from the *BMAL1* promoter ([@bibr1-0748730411401579]). Therefore, we investigated the possibility that RIP140 might function as a regulator of its activity. First, we examined whether RIP140 was able to modulate the ability of RORA to stimulate transcription from a *BMAL1* reporter in HuH7 human liver cells ([Fig. 4A](#fig4-0748730411401579){ref-type="fig"}). RIP140 expression alone led to a small increase in *BMAL1* promoter activity, potentially by means of endogenous RORs, and significantly increased the activation of the promoter by exogenously expressed RORA. RIP140 also increased the activity of RORC on the *BMAL1* promoter, suggesting that this coregulator could function as a general coactivator for this group of nuclear receptors ([Fig. 4B](#fig4-0748730411401579){ref-type="fig"}). Importantly, there was no increase in reporter activity when the ROR binding sites were mutated to abolish recruitment of the receptor to the promoter ([Fig. 4C](#fig4-0748730411401579){ref-type="fig"}). Depletion of RIP140 using RNAi ([Fig. 4G](#fig4-0748730411401579){ref-type="fig"}) reduced the basal activity of the *BMAL1* promoter, as did the depletion of RORA ([Fig. 4D](#fig4-0748730411401579){ref-type="fig"}). However, depletion of RIP140 in the absence of RORA failed to further reduce *BMAL1* reporter activity, indicating that the presence of RORA is required for RIP140 function on this promoter ([Fig. 4D](#fig4-0748730411401579){ref-type="fig"}). Moreover, the depletion of RORA using RNAi completely prevents any positive effect of RIP140 ([Fig. 4E](#fig4-0748730411401579){ref-type="fig"}). Depletion of RIP140 partially reduced the activation by RORA ([Fig. 4F](#fig4-0748730411401579){ref-type="fig"}), suggesting that, while RIP140 serves as a positive activator, other cofactors also contribute to *BMAL1* promoter activity.

![RIP140 activates the *BMAL1* promoter. HuH7 cells were cotransfected with a reporter vector containing an intact (A and B, BMAL1-Luc) or a ROREs mutant (C, 2xmtROREBMAL1-Luc) *BMAL1* promoter with RORA or RORC and increasing concentrations of RIP140 expression vectors. (D) HuH7 cells were cotransfected with a BMAL1 reporter and siRNA duplexes targeting RIP140, RORA, Rev-erbα, or a noncoding (siNC) oligo as control. (E) Cotransfection of a BMAL1 reporter with RIP140 and siRNA oligos targeting RORA. (F) Cotransfection of a BMAL1 reporter with RORA and siRNA oligos targeting RIP140. (G) Knockdown of RIP140, RORA, and Rev-erbα was confirmed by RT-QPCR. Figures representative of at least 3 independent experiments. Bars represent mean ± SEM (*n* = 6). \**p* \< 0.05, \*\**p* \< 0.01, and \*\*\**p* \< 0.001 versus control. Two-way ANOVA followed by Student Newman-Keuls multiple comparison test.](10.1177_0748730411401579-fig4){#fig4-0748730411401579}

The orphan nuclear receptor Rev-erbα reduces the expression of *BMAL1* and other genes by displacing RORA and recruiting corepressors such as NCoR ([@bibr54-0748730411401579]). To investigate whether RIP140 could increase *BMAL1* expression by suppressing Rev-erbα repressive activity, the ability of Rev-erbα knockdown and overexpression to modulate a *BMAL1* reporter was investigated. Depletion of Rev-erbα by RNAi not only increased basal activity but also RIP140-stimulated *BMAL1* promoter activity ([Fig. 5A](#fig5-0748730411401579){ref-type="fig"}). Overexpression of Rev-erbα, on the other hand, reduced the basal activity of the reporter and prevented the positive effect of RIP140 ([Fig. 5B](#fig5-0748730411401579){ref-type="fig"}). These results indicate that RIP140 is capable of acting as an activator independently of Rev-erbα.

![Rev-erbα antagonizes the effect of RIP140. (A) HuH7 cells were cotransfected with a BMAL1 reporter, siRNA duplexes targeting Rev-erbα (siRev-erbα), or a noncoding oligo (siNC) as control and increasing amounts of a RIP140 expressing vector. (B) Cotransfection of a BMAL1 reporter with an expression vector for RIP140 and increasing concentrations of a Rev-erbα expression vector. Figures representative of 3 independent experiments. Bars represent mean ± SEM (*n* = 6). \**p* \< 0.05, \*\**p* \< 0.01, and \*\*\**p* \< 0.001 versus control. ΔΔ*p* \< 0.01 and ΔΔΔ*p* \< 0.001 versus siRev-erbα (A) or RIP140 (B). Two-way ANOVA followed by Student Newman-Keuls multiple comparison test.](10.1177_0748730411401579-fig5){#fig5-0748730411401579}

Next, we examined the endogenous *BMAL1* promoter in HepG2 cells by performing ChIP experiments. We found that RIP140 was present in the vicinity of ROREs on the *BMAL1* promoter, as well as in other RORE-containing genes ([@bibr50-0748730411401579]), but not in different regions of the same genes that were examined as negative controls ([Fig. 6A](#fig6-0748730411401579){ref-type="fig"}). By sequentially immunoprecipitating for RIP140-bound chromatin and then for RORA-bound chromatin, we were able to demonstrate co-occupancy of RIP140 and RORA in the vicinity of the *BMAL1* ROREs ([Fig. 6B](#fig6-0748730411401579){ref-type="fig"}). Finally, we investigated the interaction between RIP140 and RORA by expressing epitope-tagged proteins and performing coimmunoprecipitation/Western blotting experiments using antibodies to the epitope tags. Thus, we expressed RIP140-V5 and RORA-HA and demonstrated that the 2 proteins were able to interact either by immunoprecipitating with V5 antibodies followed by Western blotting with HA antibodies or vice versa but not with an anti-GFP antibody used as a control ([Fig. 6C](#fig6-0748730411401579){ref-type="fig"}). We also demonstrated that the endogenous proteins were able to interact, albeit weakly, but this might reflect the relative avidities of the anti-RIP140 and anti-RORA antibodies to their specific epitopes. Thus, we conclude that RIP140 stimulates transcription of *BMAL1* and other clock genes by functioning as a coactivator for RORA.

![RIP140 is recruited to ROR binding elements and interacts with RORA. (A) Chromatin immunoprecipitation assay for RIP140 and RORA performed with nuclear extracts of unsynchronized HepG2 cells. Purified DNA from precipitated chromatin was amplified by real-time QPCR using primers encompassing the ROR binding elements on the *BMAL1* or *CRY1* genes. Distal regions of these genes lacking ROR binding elements were used as control. Bars represent mean ± SEM of 3 independent experiments. (B) Sequential chromatin immunoprecipitation assay (rechip). DNA immunoprecipitated with an anti-RIP140 antibody was then immunoprecipitated with an anti-RORA antibody. DNA purified after the second precipitation was amplified by real-time QPCR using primers encompassing the ROR binding elements on the *BMAL1* gene. A distal region of this gene lacking ROR binding elements was used as control. Bars represent mean ± SEM (*n* = 3). (C) HEK293 cells were transiently transfected with V5-tagged RIP140 and HA-tagged RORA expression vectors. Cells cotransfected with YFP expression vector and empty vector or GFP- and HA-tagged RORA expression vectors were used as controls. Total cell lysates were immunoprecipitated using anti-V5, anti-HA, or anti-GFP antibodies, and Western blots were performed using specific RIP140, HA, or GFP antibodies.](10.1177_0748730411401579-fig6){#fig6-0748730411401579}
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RIP140 plays an important role as a coregulator for nuclear receptors in controlling energy expenditure in adipose tissue and muscle ([@bibr32-0748730411401579]; [@bibr37-0748730411401579]; [@bibr46-0748730411401579]). In the liver, it regulates lipid and glucose homeostasis, acting either as a corepressor or as a coactivator, depending on the target gene ([@bibr21-0748730411401579]). Mounting evidence shows that the maintenance of circadian rhythms is essential to sustain a normal metabolic status ([@bibr13-0748730411401579]; [@bibr14-0748730411401579]; [@bibr25-0748730411401579]; [@bibr27-0748730411401579]) and that an intact circadian clock in the liver is required to maintain systemic glucose homeostasis ([@bibr29-0748730411401579]). Here, we show that the metabolic regulator RIP140, while it is not essential for the maintenance of circadian rhythmicity in cells, modulates clock gene expression by potentiating the activity of ROR nuclear receptors.

RIP140 expression is circadian in the liver and synchronized liver cells. Interestingly, in synchronized liver cells, RIP140 protein oscillated in phase with *BMAL1* mRNA, pointing to a possible transactivation of this gene by RIP140. We were unable to identify conserved E-boxes within the RIP140 gene. Depletion of BMAL1 led to an increase of RIP140, rather than a decrease, suggesting that it is a higher order clock-controlled gene instead of a direct target for BMAL1/CLOCK. The RIP140 locus extends over 100 Kbp with regulatory regions both intragenic and in the upstream promoter ([@bibr4-0748730411401579]; [@bibr20-0748730411401579]; [@bibr40-0748730411401579]). RIP140 contains binding regions for RORs/Rev-erbs and other circadianly expressed transcription factors ([@bibr20-0748730411401579]). Depletion of Rev-erbα in U2OS cells led to an increase in RIP140, suggesting that this nuclear receptor is a potential repressor of RIP140 expression. As RIP140 seems to be repressed by Rev-erbα, a well-known *BMAL1* target gene, we propose that RIP140 could be a second-order clock-controlled gene.

Under normal 12:12 light/dark cycles, RIP140 KO mice show significantly more activity recorded during the light phase, when the mice would normally be resting, as compared with WT controls ([@bibr22-0748730411401579]). These data suggested the possibility of alterations in the circadian system. Here, we report many and varied effects of RIP140 on the expression of clock genes: *BMAL1, CLOCK*, and *CRY1* were all found to be downregulated in the liver and AHT of RIP140 KO mice, while the effects on *PER1* and *PER2* varied depending on the tissue. As these measurements were carried out at a single time point (ZT2) instead of during a complete 24-hour period, we cannot conclude that this effect will be seen, or in fact will not change, at other times of the day. However, consistent with these data, the absence of RIP140 gave rise to a constant downregulation of *BMAL1* and *CRY1* in synchronized MEFs, and the knockdown of RIP140 in human liver cells led to the downregulation of several core clock genes, indicating that RIP140 can impact elements within the circadian clock.

Despite the reduced expression of several clock genes in synchronized RIP140 KO cells, these lines displayed relatively normal circadian periods and phases of oscillations in *BMAL1* gene reporters, indicating that RIP140 is not necessary for the oscillatory function of the molecular clock. Nevertheless, it has been suggested that smaller amplitudes of expression of clock genes, such as those seen here, can lead to decreased stability of the clock, culminating in either increased sensitivity to time cues or loss of rhythmicity after introduction of constant conditions ([@bibr13-0748730411401579]; [@bibr33-0748730411401579]; [@bibr34-0748730411401579]; [@bibr55-0748730411401579]). Thus, it is an interesting possibility to be tested in the future whether loss of RIP140 may render animals more sensitive to external factors, such as nutrition, that can affect the circadian system.

There are several metabolic similarities between the RIP140 KO mice and the *staggerer* mice (*sg/sg*) that express a dominant negative form of RORA. Both strains are lean and protected against diet-induced obesity and insulin resistance ([@bibr30-0748730411401579]; [@bibr32-0748730411401579]). In addition, RIP140 and RORA share several target genes in the liver ([@bibr24-0748730411401579]; [@bibr26-0748730411401579]). Here, we show that in liver cells, RIP140 interacts with RORA and potentiates RORs activity on the *BMAL1* promoter, providing a mechanism to explain the lower levels of clock genes in RIP140 KO animals and cells. It is important to note that not only *BMAL1* but also *CLOCK* and *CRY1* are consistently downregulated in the absence of RIP140 in tissues and cells and that all these genes are also known targets for RORA ([@bibr33-0748730411401579]). Rev-erbα, the negative component in the subsidiary feedback loop of the molecular clock, competes with RORA for the ROR binding sites and represses the expression of *BMAL1* by recruiting corepressors ([@bibr54-0748730411401579]). Therefore, we tested the alternative possibility that RIP140 may potentiate *BMAL1* expression by blocking the ability of Rev-erbα to function as a repressor. The positive effect of RIP140 was not affected by a reduction on Rev-erbα levels, indicating that the presence of this nuclear receptor is not necessary for RIP140 action. On the other hand, overexpression of Rev-erbα, displacing RORA from its binding sites, blocked the effect of RIP140.

It has been reported that other nuclear receptor coregulators, among them PGC1α, can coactivate RORA, affecting clock gene expression in the liver and other organs ([@bibr34-0748730411401579]). In other tissues, particularly in adipose tissue and muscle, RIP140 is known to suppress the catabolic effects of PGC1α ([@bibr6-0748730411401579]; [@bibr18-0748730411401579]; [@bibr51-0748730411401579]). Given these observations, it may seem surprising that both RIP140 and PGC1α are capable of serving as coactivators for the molecular clock in the liver. However, both proteins can be induced in the liver by similar signals ([@bibr5-0748730411401579]; [@bibr42-0748730411401579]), suggesting that a certain degree of cooperation between them may exist. Moreover, it has been shown that RIP140 and PGC1α can physically interact and that they can be simultaneously recruited to endogenous promoters ([@bibr18-0748730411401579]). On the other hand, RIP140 and PGC1α oscillate with different phases ([@bibr41-0748730411401579]; <http://expression.gnf.org/circadian>), which might lead to temporal compartmentalization and therefore absence of competition/interaction. The precise relation between these 2 cofactors remains to be elucidated. Finally, although RIP140 seems to regulate *BMAL1* and other clock genes via direct interaction with RORA, several other indirect mechanisms such as changes in the energy balance/oxidative status of the RIP140-depleted cells cannot be ruled out as possible causes of changes in clock function.

In summary, we showed that RIP140 is a clock-controlled gene and protein whose circadian regulation is cell autonomous and that its absence reduces the basal levels of expression of clock genes that are targets for RORs. This suggests that RIP140 can participate in a feedback loop that connects metabolism to circadian rhythms and that the absence of RIP140 might affect the robustness of the system and its sensitivity to external stimuli.
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